FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ergocalciferol 250microgram tablets (Celltech Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 250microgram tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergoral 10,000unit tablets (Cubic Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 250microgram tablets (Unichem Plc) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 250microgram tablets (Celltech Pharmaceuticals Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 250microgram tablets (A A H Pharmaceuticals Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergoral 10,000unit tablets (Cubic Pharmaceuticals Ltd) 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Strepsils Children 6+ lozenges (Reckitt Benckiser Healthcare (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Strepsils Sore Throat and Cough lozenges (Reckitt Benckiser Healthcare (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free 24 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free 12 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) 12 tablet 2 x 6 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) 24 tablet 4 x 6 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Strepsils Children 6+ lozenges (Reckitt Benckiser Healthcare (UK) Ltd) 24 lozenge 2 x 12 lozenges VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Strepsils Sore Throat and Cough lozenges (Reckitt Benckiser Healthcare (UK) Ltd) 24 lozenge 2 x 12 lozenges VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Potter's Newrelax tablets 60 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Potter's Antifect tablets 60 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Potter's Antifect tablets (Potter's (Herbal Supplies) Ltd) 60 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Potter's Newrelax tablets (Potter's (Herbal Supplies) Ltd) 60 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely estradiol 600 microgram/1 gram conventional release cutaneous gel (clinical drug) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Progesterone micronised 100mg capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Progesterone micronised 200mg capsules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Estradiol 0.06% gel 64 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Utrogestan 100mg capsules (Ferring Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oestrogel Pump-Pack 0.06% gel (Lexon (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oestrogel Pump-Pack 0.06% gel (Aventis Pharma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Estradiol 0.06% gel 80 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oestrogel Pump-Pack 0.06% gel (Sigma Pharmaceuticals Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Utrogestan 200mg capsules (Ferring Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Progesterone micronised 200mg capsules 15 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oestrogel Pump-Pack 0.06% gel (Stephar (U.K.) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oestrogel Pump-Pack 0.06% gel (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Progesterone micronised 100mg capsules 30 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oestrogel Pump-Pack 0.06% gel (Necessity Supplies Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oestrogel Pump-Pack 0.06% gel (PI) (Waymade Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oestrogel Pump-Pack 0.06% gel (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Utrogestan 100mg capsules (Ferring Pharmaceuticals Ltd) 30 capsule 2 x 15 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oestrogel Pump-Pack 0.06% gel (Sigma Pharmaceuticals Plc) 80 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Utrogestan 200mg capsules (Ferring Pharmaceuticals Ltd) 15 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oestrogel Pump-Pack 0.06% gel (Necessity Supplies Ltd) 64 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oestrogel Pump-Pack 0.06% gel (Aventis Pharma) 80 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oestrogel Pump-Pack 0.06% gel (PI) (Waymade Ltd) 80 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oestrogel Pump-Pack 0.06% gel (Stephar (U.K.) Ltd) 80 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oestrogel Pump-Pack 0.06% gel (Mawdsley-Brooks & Company Ltd) 80 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oestrogel Pump-Pack 0.06% gel (Doncaster Pharmaceuticals Ltd) 80 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oestrogel Pump-Pack 0.06% gel (Lexon (UK) Ltd) 80 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 0.5% eye drops (Waymade Healthcare Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 1.25mg capsules (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 2.5mg capsules (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 5mg capsules (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 0.5% eye drops (Waymade Healthcare Plc) 10 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (Waymade Healthcare Plc) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Waymade Healthcare Plc) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 1.25mg capsules (Waymade Healthcare Plc) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 2.5mg capsules (Waymade Healthcare Plc) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 5mg capsules (Waymade Healthcare Plc) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium chloride 292.5mg/5ml (1mmol/ml) oral solution sugar free VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium chloride 292.5mg/5ml (1mmol/ml) oral solution sugar free 100 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium chloride 292.5mg/5ml (1mmol/ml) oral solution sugar free (Special Order) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium chloride 292.5mg/5ml (1mmol/ml) oral solution sugar free 1 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
SodiClor 292.5mg/5ml (1mmol/ml) oral solution sugar free (Arjun Products Ltd) (product) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
S-Chlor SF 292.5mg/5ml (1mmol/ml) oral solution (Ennogen Healthcare Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
S-Chlor SF 292.5mg/5ml (1mmol/ml) oral solution (Ennogen Healthcare Ltd) 100 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium chloride 292.5mg/5ml (1mmol/ml) oral solution sugar free (Special Order) 1 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
SodiClor 292.5mg/5ml (1mmol/ml) oral solution sugar free (Arjun Products Ltd) 100 ml (product) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg tablets (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 20mg tablets (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 40mg gastro-resistant capsules (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (Waymade Healthcare Plc) 120 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg tablets (Waymade Healthcare Plc) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 20mg tablets (Waymade Healthcare Plc) 84 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Waymade Healthcare Plc) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 40mg gastro-resistant capsules (Waymade Healthcare Plc) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely sodium nitroprusside dihydrate 50 milligram/1 vial powder for conventional release solution for injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials 5 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (UniChem Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (UniChem Ltd) 5 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) 5 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium nitroprusside 50mg powder for solution for injection vials (Mayne Pharma Plc) 5 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Aprotinin 10,000kiu/mL injection solution 100mL vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Trasylol 140mg/100ml solution for injection vials (Bayer Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Aprotinin 140mg/100ml solution for injection vials 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Trasylol 140mg/100ml solution for injection vials (Bayer Plc) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Pyrazinamide 500mg tablets 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zinamide 500mg tablets (Genus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levothyroxine sodium 100micrograms/5ml oral solution sugar free (Teva UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levothyroxine sodium 100micrograms/5ml oral solution sugar free (Teva UK Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely biperiden hydrochloride 2 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Biperiden 2mg tablets (Imported (Germany)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Biperiden 2mg tablets 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Akineton 2mg tablets (Abbott Laboratories Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Akineton 2mg tablets (Abbott Laboratories Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Biperiden 2mg tablets (Imported (Germany)) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gygel 2% contraceptive jelly (Marlborough Pharmaceuticals Ltd) 81 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 52 of 86 Next End

This concept is not in any reference sets

Back to Start